[Translation] To evaluate the efficacy and safety of injectable Agkistrodon acutus thrombin in reducing blood loss in posterior lumbar interbody fusion surgery with placebo as control
To evaluate the efficacy and safety of injectable Agkistrodon acutus thrombin in reducing blood loss during posterior lumbar interbody fusion surgery, using placebo (dextran 20) as control, and to conduct dose exploration.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.